Debut Plus

₹417.45

▼ -1.93 -0.46%

18 Jul 2026

NSE Listed

Syngene International Ltd. (SYNGENE)

Volume: 7,86,042Avg Vol 1W: 8,27,770.4Avg Vol 1M: 9,22,665.452W Range:₹380₹728.6
NSE BSE www.syngeneintl.com
Key Ratios
Checked 21h ago
Market Cap₹16,932 Cr
Current Price₹417.45
Previous Close₹419.38
High / Low (52w)₹728.6 / ₹380
Volume7,86,042
Avg Vol (1W)8,27,770.4
Avg Vol (1M)9,22,665.4
Stock P/E62.43
Book Value₹115.25
Dividend Yield—
ROE10.6%
ROA—
Revenue (TTM)₹3,714 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹10
EPS (TTM)₹11.63
P/B6.3
Debt / Equity0.07
50 DMA₹442.18
200 DMA₹516.16
Day change-0.46%
Price Chart
₹417.45▼ 37.73% · 1Y
₹722₹3905.9Cr
2025-07-17
2026-07-16

20-day avg volume: 9.2L shares

Pros
  • Company is almost debt-free.
Cons
  • Stock trades at a high P/E of 62.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹790 Cr₹891 Cr₹944 Cr₹1,018 Cr₹875 Cr₹911 Cr₹917 Cr₹1,037 Cr
EBITDA₹81 Cr₹150 Cr₹193 Cr₹256 Cr₹113 Cr₹98 Cr₹111 Cr₹214 Cr
Net Profit₹76 Cr₹106 Cr₹131 Cr₹183 Cr₹87 Cr₹67 Cr₹15 Cr₹148 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹1,901 Cr₹2,094 Cr₹2,249 Cr₹2,712 Cr₹3,264 Cr₹3,579 Cr₹3,714 Cr₹3,809 Cr
EBITDA₹448 Cr₹480 Cr₹462 Cr₹539 Cr₹639 Cr₹679 Cr₹681 Cr₹536 Cr
Net Profit₹332 Cr₹412 Cr₹405 Cr₹396 Cr₹464 Cr₹510 Cr₹496 Cr₹317 Cr
EPS8.3610.3510.119.8211.5112.6912.347.87
Balance Sheet
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹3,704 Cr₹4,163 Cr₹4,883 Cr₹5,564 Cr₹5,831 Cr₹6,152 Cr₹6,796 Cr₹7,055 Cr
Total Liabilities₹1,735 Cr₹1,987 Cr₹2,062 Cr₹2,266 Cr₹2,213 Cr₹1,894 Cr₹2,069 Cr₹2,216 Cr
Equity₹1,968 Cr₹2,176 Cr₹2,821 Cr₹3,298 Cr₹3,618 Cr₹4,258 Cr₹4,727 Cr₹4,839 Cr
Total Debt————————
Cash Flow
MetricMar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹727 Cr₹784 Cr₹785 Cr₹686 Cr₹960 Cr₹1,167 Cr₹1,283 Cr₹985 Cr
Investing₹-646 Cr₹-428 Cr₹-628 Cr₹-611 Cr₹-656 Cr₹-496 Cr₹-745 Cr₹-860 Cr
Financing₹-72 Cr₹-225 Cr₹58 Cr₹-31 Cr₹-342 Cr₹-551 Cr₹-142 Cr₹-215 Cr
Free Cash Flow₹727 Cr₹784 Cr₹785 Cr₹686 Cr₹960 Cr₹1,167 Cr₹1,283 Cr₹985 Cr
Shareholding
Promoter 52.68% Institutions 40.34% Public 6.98%
Efficiency & Working Capital
ROCE9.7%
Interest Coverage10.9
Dividend Payout—
Debtor Days50 d
Inventory Days14 d
Payable Days34 d
Cash Conversion Cycle30 d
Working Capital Days63 d
Shareholding Details

As of 2026-03-31

Promoter52.7%
FII13.9%
DII26.4%
Institutions40.3%
Public7%
Promoter Pledge0%
No. of Shareholders1,35,605
Shareholding Pattern

Quarterly — figures in %. Latest 12 quarters.

PeriodJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters54.8%54.8%54.8%54.8%54.7%54.7%52.7%52.7%52.7%52.7%52.7%52.7%
FIIs23.2%23.6%21.2%20.9%20.6%20.7%20.6%19.5%16.5%16.3%15%13.9%
DIIs11.2%9.9%13.1%15.8%16.8%17.5%19.5%21.5%24%24.6%25.8%26.4%
Public10.8%11.7%10.9%8.5%7.8%7.1%7.1%6.3%6.8%6.4%6.5%7%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders1,25,4551,25,9921,21,8801,15,8501,20,0181,07,3381,28,8061,25,0901,42,3101,36,0611,31,7501,35,605
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Biocon LimitedShareholding of Promoter and Promoter Group52.4%21.12 Cr
Nippon Life India Trustee Ltd-a/c Nippon India RetPublic Shareholding6%2.41 Cr
Icici Prudential S&p Bse 500 EtfPublic Shareholding5.4%2.17 Cr
Dsp Arbitrage FundPublic Shareholding4.8%1.91 Cr
Mirae Asset Multicap FundPublic Shareholding3.3%1.32 Cr
Government Of SingaporePublic Shareholding2.9%1.16 Cr
Government Pension Fund GlobalPublic Shareholding1.8%73,42,967
Lic New Pension Plus Growth FundPublic Shareholding1.8%71,83,419
Uti Balanced Advantage FundPublic Shareholding1.2%46,67,740
Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar)Shareholding of Promoter and Promoter Group0.3%10,53,633
Kiran Mazumdar ShawShareholding of Promoter and Promoter Group0%21,964
Ravi Rasendra MazumdarShareholding of Promoter and Promoter Group0%8,806
Biocon Research LimitedShareholding of Promoter and Promoter Group0%0
Dev MazumdarShareholding of Promoter and Promoter Group0%13,686
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Kiran Mazumdar Shaw00%2026-03-31
Ravi Rasendra Mazumdar00%2026-03-31
Biocon Limited00%2026-03-31
Biocon Limited Employee Welfare Trust (murali Krishnan K N And K Nanda Kumar)00%2026-03-31
Biocon Research Limited00%2026-03-31
Dev Mazumdar00%2026-03-31
Icici Prudential S&p Bse 500 Etf00%2026-03-31
Dsp Arbitrage Fund00%2026-03-31
Nippon Life India Trustee Ltd-a/c Nippon India Ret00%2026-03-31
Uti Balanced Advantage Fund00%2026-03-31
Mirae Asset Multicap Fund00%2026-03-31
Lic New Pension Plus Growth Fund00%2026-03-31
Board of Directors
NameDesignationYear
Kiran Mazumdar ShawExecutive Chairman2026
Peter John BainsManaging Director & CEO2026
Catherine Patricia RosenbergNon-Exec & Non-Independent Dir2026
Vinita BaliNon-Exec & Non-Independent Dir2026
Kush ParmarIndependent Non Exe. Director2026
Sharmila KarveLead Independent Non Executive Director2026
Nilanjan RoyIndependent Non Exe. Director2026
Manja BoermanIndependent Non Exe. Director2026
Sanjaya SinghIndependent Non Exe. Director2026
Suresh NarayananIndependent Non Exe. Director2026
Arun Suresh ChandavarkarIndependent Director2026
Chethan YogeshCompany Sec. & Compli. Officer2026
Vijaya ChandruIndependent Director2026
Segments — Product
SegmentRevenueShare
Providing contract research and man₹0 Cr—
Segments — Geography
RegionRevenueShare
India₹136 Cr4%
United States of America₹2,198 Cr64.2%
Europe₹952 Cr27.8%
Rest of the World₹139 Cr4.1%
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹10500403403
Corporate Actions
TypeDateValueRemark
forthcoming2026-07-29Board Meetings—
dividend2026-06-25₹1.25 (12.5%)Final
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262810033230597
2026257003321336
202624000209261
Insider / Designated-Person Trades

30 recent disclosure(s)

ANJAN CHAKRABARTIDisposal · 6,190
ANJAN CHAKRABARTIDisposal · 27,200
ANJAN CHAKRABARTIAcquisition · 58,390
BIOCON LIMITEDDisposal · 80,00,000
DEEPAK VENKATRAMANDisposal · 600
DEEPAK VENKATRAMANDisposal · 600
Substantial Acquisitions (SAST)

2 disclosure(s)

Market08/05/2025 · 3,61,572
Market10/12/2024 · 80,00,000
Company Information
Incorporated1993
ChairmanKiran Mazumdar Shaw
AuditorB S R & Co LLP
Investor Email[email protected]; Mayank.Verma@syngeneintl
🌐 www.syngeneintl.com ↗

📍 Biocon SEZ Biocon Park, Plot No 2 & 3 Bommasandra Inds, Bengaluru, Karnataka, 560099

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

SWELECT Energy Sys Ltd.Swiggy LimitedStrlng & Wil Ren Ene Ltd.Sylvan Plyboard (India) LimitedSymphony LimitedSyncom Formu (I) Ltd.Synoptics Technologies LimitedSyrma SGS Technology Ltd.Systango Technologies Ltd.Systematix Corp Service LimitedTaaL Tech Ltd.TAC Infosec LimitedAll “S” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search